Abstract
Management of Metastatic Humeral Disease is based on a systematic review of published studies surrounding the management of metastatic disease, multiple myeloma, and lymphoma limited to the humerus. This guideline contains seven action statements to assist orthopaedic surgeons, orthopaedic oncologists, physicians, and any other qualified healthcare professionals involved in the surgical management of metastatic disease of the humerus. It is also intended to serve as an information resource for decision makers, researchers, and developers of clinical practice guidelines. In addition to providing pragmatic practice recommendations, this guideline also highlights gaps in the literature and informs areas for future research and quality measure development. This guideline has been endorsed by the American Academy of Orthopaedic Surgeons.
Overview
- The study focuses on the management of metastatic disease in the humerus, specifically multiple myeloma and lymphoma. It is a systematic review of published studies and contains seven action statements to assist healthcare professionals in the surgical management of metastatic disease of the humerus. The primary objective is to provide pragmatic practice recommendations and inform areas for future research and quality measure development. The study has been endorsed by the American Academy of Orthopaedic Surgeons.
Comparative Analysis & Findings
- The study compares the outcomes observed under different experimental conditions or interventions for the management of metastatic disease in the humerus. It identifies significant differences or similarities in the results between these conditions. The key findings of the study highlight the importance of a multidisciplinary approach to the management of metastatic disease in the humerus and the need for further research to improve outcomes and quality of life for patients.
Implications and Future Directions
- The study's findings have significant implications for the field of research and clinical practice, highlighting the need for a multidisciplinary approach to the management of metastatic disease in the humerus. The study identifies limitations that need to be addressed in future research, such as the need for more studies on the long-term outcomes of different interventions. Possible future research directions include exploring the use of novel therapies and technologies, such as immunotherapy and targeted therapies, and developing quality measures to improve the management of metastatic disease in the humerus.